Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.590
+0.020 (0.78%)
At close: Apr 28, 2026, 4:00 PM EDT
2.650
+0.060 (2.32%)
After-hours: Apr 28, 2026, 7:29 PM EDT
Nautilus Biotechnology Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$4.00
Upside
+54.44%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $2.5 → $4 | Strong Buy | Maintains | $2.5 → $4 | +54.44% | Feb 27, 2026 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $2.25 → $1.75 | Hold → Strong Sell | Downgrades | $2.25 → $1.75 | -32.43% | Dec 5, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +131.66% | Jun 27, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Initiates $5 → $3 | Strong Buy → Hold | Initiates | $5 → $3 | +15.83% | Jun 3, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $6 | Hold | Reiterates | $6 | +131.66% | Aug 3, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +131.66% | Aug 3, 2022 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | -22.78% | Aug 3, 2022 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +54.44% | Jul 14, 2022 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $9 → $5 | Hold | Maintains | $9 → $5 | +93.05% | Apr 13, 2022 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $8 | Hold | Initiates | $8 | +208.88% | Jan 6, 2022 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 2, 2021 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $10 | Hold | Initiates | $10 | +286.10% | Aug 4, 2021 |
| Jefferies | Jefferies | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +401.93% | Jul 13, 2021 |